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Background
Criteria for the Sepsis-3 definition of septic shock include vasopressor treatment to
maintain a mean arterial pressure > 65 mmHg and a lactate concentration > 2 mmol/L.
The impact of hyperoxia in patients with septic shock using these criteria is unknown.
Methods
A post hoc analysis was performed of the HYPER2S trial assessing hyperoxia versus
normoxia in septic patients requiring vasopressor therapy, in whom a plasma lactate
value was available at study inclusion. Mortality was compared between patients
fulfilling the Sepsis-3 septic shock criteria and patients requiring vasopressors for
hypotension only (i.e., with lactate ≤ 2 mmol/L).
Results
Of the 434 patients enrolled, 397 had available data for lactate at inclusion. 230 had
lactate > 2 mmol/L and 167 ≤ 2 mmol/L. Among patients with lactate > 2 mmol/L, 108
and 122 were “hyperoxia”- and “normoxia”-treated, respectively. Patients with
lactate > 2 mmol/L had significantly less COPD more cirrhosis and required surgery
more frequently. They also had higher illness severity (SOFA 10.6 ± 2.8 vs. 9.5 ± 2.5,
p = 0.0001), required more renal replacement therapy (RRT), and received
vasopressor and mechanical ventilation for longer time. Mortality rate at day 28 was
higher in the “hyperoxia”-treated patients with lactate > 2 mmol/L as compared to
“normoxia”-treated patients (57.4% vs. 44.3%, p = 0.054), despite similar RRT
requirements as well as vasopressor and mechanical ventilation-free days. A
multivariate analysis showed an independent association between hyperoxia and
mortality at day 28 and 90. In patients with lactate ≤ 2 mmol/L, hyperoxia had no
effect on mortality nor on other outcomes.
Conclusions
Our results suggest that hyperoxia may be associated with a higher mortality rate in
patients with septic shock using the Sepsis-3 criteria, but not in patients with
hypotension alone.
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